Cannabinoid Biosynthesis Market Size is predicted to witness a 14.2% CAGR during the forecast period for 2023-2031.
Cannabinoids found in the cannabis sativa plant. The plant contains about 480 distinct chemicals, including 66 cannabinoids. Biosynthesis is the process by which cannabinoids are produced. Enzymatic reactions using substances derived from either natural or synthetic sources are carried out in controlled environments in laboratories to carry out the process. The market for pharmaceuticals derived from cannabinoids is being propelled by the potential medicinal benefits of these compounds, which include the alleviation of chemotherapy-related symptoms, chronic pain, and muscular spasms. The market for cannabinoid biosynthesis is expected to grow as more is learned about its therapeutic effects through research. Products derived from cannabinoids have seen a surge in demand due to the popularity of alternative medicine is growing and also the growing preference for natural and plant-based healthcare solutions. Furthermore, products derived from cannabinoids are in high demand due to the global trend toward legalizing cannabis. The need for biosynthetic cannabinoids is predicted to rise as the usage of medicinal cannabis, and its derivatives becomes legal in more nations.
However, the market growth is hampered by the lack of awareness of the safety as well as health of the cannabinoid biosynthesis market and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high humidity cannabinoid biosynthesis. Cannabinoid biosynthesis is still in its infancy in comparison to more established ways of cannabinoid manufacturing, which poses problems in terms of funding for research and development. Potentially stunting market expansion is the current state of knowledge on the safety and long-term impacts of biosynthetic cannabinoids.
The widespread prejudice and discrimination that surrounds cannabis usage, especially when used medicinally, can have an impact on how widely used and accepted cannabinoid products are. Market expansion could be stunted if consumers and healthcare providers are misled about the safety and effectiveness of cannabis. Several cannabinoid-based products, including cannabinol, cannabigerol, and cannabidiolic acid, were affected by the COVID-19 pandemic. The early months of the epidemic saw panic buying, which further reduced product appeal, priority, and sales.
The cannabinoid biosynthesis market is segmented based on type and application. Based on type, the market is segmented into balanced THC and CBD, cannabidiol-dominant, THC-dominant, and others. The application segment is segmented into pain management, anxiety management, appetite stimulation, and nausea management.
The anxiety management cannabinoid biosynthesis market will hold a major global market share in 2022. The anxiety management subsegment is likely to grow faster than any other. There has been a rise in the usage of cannabinoids as an alternative treatment option for stress and anxiety, with CBD, in particular, showing promise in this regard. This subsegment of the cannabinoid biosynthesis market has been expanding due to rising customer knowledge of cannabis' medicinal properties and the need for safe, effective alternatives to pharmaceutical anxiety treatments.
The THC-dominant industry makes up the bulk of cannabinoid biosynthesis usage because of its euphoric properties; tetrahydrocannabinol, or THC, is used both recreationally and medicinally, particularly for the treatment of nausea and chronic pain. The THC-dominant segment of the cannabinoid biosynthesis market is experiencing rapid expansion because of the increasing legalization of cannabis in various places and the increasing adoption of THC-based products, especially in countries like the US, Germany, the UK, China, and India.
The North American cannabinoid biosynthesis market is expected to register the maximum market share in revenue in the near future. It can be attributed to the fact that many states have passed legislation decriminalizing cannabis for both recreational and medical use. The result is a strong market for goods derived from cannabis. In addition, Asia Pacific is estimated to grow rapidly in the global cannabinoid biosynthesis market because of the increasing legality of cannabinoid-based medicines, the rising popularity of medical cannabis, and the diversified healthcare demands of the growing population.
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 14.2% from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type, Application Type |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Hyasynth Biologicals, Amyris Inc, Demetrix, Jazz Pharmaceuticals PLC, Lygos, Renew Biopharma, CB Therapeutics, Canopy Growth Corp, Zymergen Inc, Cronos Group Inc., Creo, Constellation Brands Inc, Evolva Holding SA, Willow Biosciences Inc, InMed Pharmaceuticals, Purisys and Others. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cannabinoid Biosynthesis Market Snapshot
Chapter 4. Global Cannabinoid Biosynthesis Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Type:
5.2.1. Balanced THC and CBD
5.2.2. Cannabidiol Dominant
5.2.3. THC Dominant
5.2.4. Others
Chapter 6. Market Segmentation 2: By Application Type Estimates & Trend Analysis
6.1. By Application Type & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for following By Application Type:
6.2.1. Pain Management
6.2.2. Anxiety Management
6.2.3. Appetite Stimulation
6.2.4. Nausea Management
Chapter 7. Cannabinoid Biosynthesis Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Cannabinoid Biosynthesis Market revenue (US$ Million) estimates and forecasts By Type, 2019-2031
7.1.2. North America Cannabinoid Biosynthesis Market revenue (US$ Million) estimates and forecasts By Application Type, 2019-2031
7.1.3. North America Cannabinoid Biosynthesis Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
7.1.4. Europe
7.1.5. Europe Cannabinoid Biosynthesis Market revenue (US$ Million) By Type, 2019-2031
7.1.6. Europe Cannabinoid Biosynthesis Market revenue (US$ Million) By Application Type, 2019-2031
7.1.7. Europe Cannabinoid Biosynthesis Market revenue (US$ Million) by country, 2019-2031
7.1.8. Asia Pacific
7.1.9. Asia Pacific Cannabinoid Biosynthesis Market revenue (US$ Million) By Type, 2019-2031
7.1.10. Asia Pacific Cannabinoid Biosynthesis Market revenue (US$ Million) By Application Type, 2019-2031
7.1.11. Asia Pacific Cannabinoid Biosynthesis Market revenue (US$ Million) by country, 2019-2031
7.1.12. Latin America
7.1.13. Latin America Cannabinoid Biosynthesis Market revenue (US$ Million) By Type, (US$ Million) 2019-2031
7.1.14. Latin America Cannabinoid Biosynthesis Market revenue (US$ Million) By Application Type, (US$ Million) 2019-2031
7.1.15. Latin America Cannabinoid Biosynthesis Market revenue (US$ Million) by country, 2019-2031
7.1.16. Middle East & Africa
7.1.17. Middle East & Africa Cannabinoid Biosynthesis Market revenue (US$ Million) By Type, (US$ Million) 2019-2031
7.1.18. Middle East & Africa Cannabinoid Biosynthesis Market revenue (US$ Million) By Application Type, (US$ Million) 2019-2031
7.1.19. Middle East & Africa Cannabinoid Biosynthesis Market revenue (US$ Million) by country, 2019-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Hyasynth Biologicals,
8.2.2. Amyris Inc,
8.2.3. Demetrix,
8.2.4. Jazz Pharmaceuticals PLC,
8.2.5. Lygos,
8.2.6. Renew Biopharma,
8.2.7. CB Therapeutics,
8.2.8. Canopy Growth Corp,
8.2.9. Zymergen Inc,
8.2.10. Cronos Group Inc.,
Cannabinoid Biosynthesis Market By Type-
Cannabinoid Biosynthesis Market By Application Type-
Cannabinoid Biosynthesis Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
